Bundling Arrows: Improving Translational CNS Drug Development by Integrated PK/PD-metabolomics

Expert Opinion on Drug Discovery - United Kingdom
doi 10.1080/17460441.2018.1446935
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors
Publisher

Informa UK Limited

Related search

Population PK/PD Analysis

2010English

Advances in CNS Drug Development

2019English

Basic PK/PD Principles of Drug Effects in Circular/Proliferative Systems for Disease Modelling

Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology
2010English

Swine in Translational Research and Drug Development

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2016English

Improving Environmental Decision‐Making Through Integrated Governance, Public Engagement, and Translational Approaches

The Bulletin of the Ecological Society of America
2020English

Drug Repurposing as an Efficient Strategy in Drug Development – Example of CNS Area

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Depicting the Evolving Scenario of Translational-Guided Drug Development

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2012English

Dabigatran Exposure and Outcomes: A PK/PD/PV Study

Clinical Therapeutics
Pharmacology
2017English

Pediatric Ontogeny: Moving From Translational Science to Drug Development

Journal of Clinical Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy